Thus, while one of the basic problems in cancer therapy is a paucity of anti-tumor CD8+ T cells, one problem with T-cell-mediated control of HIV appears to be that while a broad CD8+ T-cell repertoire is generated, only a few of these T cells are effective at suppressing viral replication. The gene discussed is CD8A; the disease is cancer.